A Randomised, Open-Label, Assessor-Blind, Parallel Groups, Multicentre Trial Comparing the Efficacy of MENOPUR Versus Recombinant FSH in Controlled Ovarian Stimulation Following a GnRH Antagonist Protocol and Single Embryo Transfer.

Trial Profile

A Randomised, Open-Label, Assessor-Blind, Parallel Groups, Multicentre Trial Comparing the Efficacy of MENOPUR Versus Recombinant FSH in Controlled Ovarian Stimulation Following a GnRH Antagonist Protocol and Single Embryo Transfer.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jan 2015

At a glance

  • Drugs Menotropin (Primary) ; Follitropin beta
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms MEGASET
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Apr 2012 Actual patient number changed from (754) to (749) as reported by ClinicalTrials.gov.
    • 19 Apr 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top